ED Observation for Opioid Use Disorder
Launched by NYU LANGONE HEALTH · Sep 23, 2021
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "ED Observation for Opioid Use Disorder" is exploring how different ways of providing care can help people struggling with opioid use disorder (OUD) when they visit the emergency department (ED). Specifically, the trial compares a standard ED visit with an extended visit that involves extra support and observation. This study is taking place at several hospitals in New York and is currently looking for participants.
To be eligible for this trial, you need to be at least 18 years old, able to communicate in English, and have a history of using opioids without a prescription. You also shouldn’t be receiving any formal treatment for opioid use disorder at the time of your visit. If you decide to participate, you will be randomly assigned to either the standard or the enhanced care option, and you'll need to agree to follow up assessments at certain points after your visit. This study aims to find out which approach works better for helping patients with opioid use disorder, so your participation could contribute to improving future care for others in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Is 18 years of age or older
- • Is able to speak English sufficiently to understand study procedures
- • Has a history of non-medical opioid use
- • Is a potential candidate for ED-based MOUD treatment initiation and referral at the site as confirmed by clinical staff
- • s not receiving MOUD through ongoing formal addiction treatment or pain management at the time of index ED visit
- • Is willing to receive either standard ED care or enhanced ED care in EDOU depending on random assignment
- • Presents to the ED during study screening hours
- Exclusion Criteria:
- • Unwilling or unable to provide written/electronic informed consent/HIPAA Authorization for research procedures, including research visits at baseline and Day 30 and Day 90, and/or consent for the release of health records and data matching for a period of 2 years following enrollment and 1 year prior to enrollment.
- • Currently in jail, prison or any inpatient overnight facility as required by court of law or have pending legal action or that could prevent participation in the study
- • Presents from a medical-based extended care facility (e.g., skilled nursing facility)
- • Previous participation in the current study
- • Inadequate locator information (unable or unwilling to provide one unique mean of contact).
- • Has acute, severe medical, psychiatric, or concurrent substance use problem or meets other criteria that would exclude the patient (clinically) from placement in EDOU according to EDOU placement clinical protocols.
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Brooklyn, New York, United States
New Hyde Park, New York, United States
New York, New York, United States
Staten Island, New York, United States
Newark, New Jersey, United States
Patients applied
Trial Officials
Ryan McCormack, MD
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials